Report Detail
COVID-19 Impact on Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, Market Insights and Forecast to 2026
- RnM4077588 |
- 25 June, 2020 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market is segmented into
Preface
Eluxadoline
Alosetron
Rifaximin
Loperamide
Diphenoxylate + Atropine
Dicyclomine and Hyoscyamine
Segment by Application, the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market is segmented into
Hospitals
Clinics
Others
Regional and Country-level Analysis
The Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Analysis
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs business, the date to enter into the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs product introduction, recent developments, etc.
The major vendors covered:
Astellas Pharmaceuticals
Actavis
Pfizer
GlaxoSmithKline
Salix Pharmaceuticals Ltd
AstraZenenca
...
1 Study Coverage
- 1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by Type
- 1.4.2 Preface
- 1.4.3 Eluxadoline
- 1.4.4 Alosetron
- 1.4.5 Rifaximin
- 1.4.6 Loperamide
- 1.4.7 Diphenoxylate + Atropine
- 1.4.8 Dicyclomine and Hyoscyamine
- 1.5 Market by Application
- 1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by Application
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry
- 1.6.1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Estimates and Forecasts
- 2.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2015-2026
- 2.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2015-2026
- 2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Competitor Landscape by Players
- 3.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers
- 3.1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers
- 3.2.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue in 2019
- 3.2.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Manufacturers
- 3.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2015-2020)
- 4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2015-2020)
- 4.1.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2015-2020)
- 5.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Application (2015-2020)
- 5.1.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Application (2015-2020)
- 5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
- 6.1.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
- 6.1.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Type
- 6.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
- 7.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
- 7.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Type
- 7.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region
- 8.1.1 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region
- 8.1.2 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
- 9.1.1 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
- 9.1.2 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Type
- 9.3 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
- 10.1.1 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
- 10.1.2 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Astellas Pharmaceuticals
- 11.1.1 Astellas Pharmaceuticals Corporation Information
- 11.1.2 Astellas Pharmaceuticals Description, Business Overview and Total Revenue
- 11.1.3 Astellas Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
- 11.1.5 Astellas Pharmaceuticals Recent Development
- 11.2 Actavis
- 11.2.1 Actavis Corporation Information
- 11.2.2 Actavis Description, Business Overview and Total Revenue
- 11.2.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
- 11.2.5 Actavis Recent Development
- 11.3 Pfizer
- 11.3.1 Pfizer Corporation Information
- 11.3.2 Pfizer Description, Business Overview and Total Revenue
- 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
- 11.3.5 Pfizer Recent Development
- 11.4 GlaxoSmithKline
- 11.4.1 GlaxoSmithKline Corporation Information
- 11.4.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
- 11.4.5 GlaxoSmithKline Recent Development
- 11.5 Salix Pharmaceuticals Ltd
- 11.5.1 Salix Pharmaceuticals Ltd Corporation Information
- 11.5.2 Salix Pharmaceuticals Ltd Description, Business Overview and Total Revenue
- 11.5.3 Salix Pharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
- 11.5.5 Salix Pharmaceuticals Ltd Recent Development
- 11.6 AstraZenenca
- 11.6.1 AstraZenenca Corporation Information
- 11.6.2 AstraZenenca Description, Business Overview and Total Revenue
- 11.6.3 AstraZenenca Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
- 11.6.5 AstraZenenca Recent Development
- 11.1 Astellas Pharmaceuticals
- 11.1.1 Astellas Pharmaceuticals Corporation Information
- 11.1.2 Astellas Pharmaceuticals Description, Business Overview and Total Revenue
- 11.1.3 Astellas Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
- 11.1.5 Astellas Pharmaceuticals Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Estimates and Projections by Region
- 12.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs. Industry analysis & Market Report on COVID-19 Impact on Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs is a syndicated market report, published as COVID-19 Impact on Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
